Method for extracting cantharidin from cantharides
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- JIANGSU SIHUAN BIOENG
- Publication Date
- 2012-02-01
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a method for extracting cantharidin from cantharidin. Background technique
[0002] Methyleatharidinimide is a derivative of cantharidin, which has a great effect on both anti-cancer and whitening. It has a direct killing and inhibiting effect on cancer cells; it stimulates the bone marrow hematopoietic system and increases blood white blood cells. .
[0003] More than 2,000 years ago, Chinese medicine in my country began to use mylabris to treat tumors. The medicine is pungent and cold in nature, poisonous, can attack toxins and erode sores, break blood and dissipate stagnation, and is a traditional Chinese medicine with obvious effects. However, the side effects are very serious. After taking it, the mucous membranes of the oral cavity and pharynx are congested, nausea and vomiting, loss of appetite, diarrhea, dysuria, frequent urination, hematuria, etc. And can not control the dosage of medicine, be difficult to apply cli...